摘要
胶质瘤是中枢神经系统最常见的原发性肿瘤,尽管临床选择多模式治疗,但大多数患者的总体预后很差,特别是胶质母细胞瘤,这与胶质瘤的生物学特性有关。而基因的改变已被证实与胶质母细胞瘤的发生密切相关。不同的基因表达对胶质瘤的治疗和预后具有指导作用,深入了解胶质瘤背后的基因与疾病的关系,将有助于探索潜在的个体化靶向治疗方法。
Glioma is the most common primary tumor of the central nervous system.Although clinicians select multimodal treatment,the overall prognosis of most patients is still very poor,especially glioblastoma(GB),which is related to the biological characteristics of glioma.Genomic alterations have been confirmed to be closely related to the tumorigenesis of GB.Different gene expression has a guiding therapeutic and prognostic predictive function for gliomas,so the deeper understanding of the relationship between genes and diseases behind gliomas will enable us to explore potential individualized targeted therapies for patients.
作者
赵聪选
于韬
Zhao Congxuan;Yu Tao(Department of Diagnostic Ultrasound,Cancer Hospital of China Medical University,Liaoning Cancer Hospital&Institute,Shenyang 110042,China)
出处
《国际肿瘤学杂志》
CAS
2020年第5期293-296,共4页
Journal of International Oncology
